Your browser doesn't support javascript.
loading
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.
Cometta, A; Calandra, T; Gaya, H; Zinner, S H; de Bock, R; Del Favero, A; Bucaneve, G; Crokaert, F; Kern, W V; Klastersky, J; Langenaeken, I; Micozzi, A; Padmos, A; Paesmans, M; Viscoli, C; Glauser, M P.
Affiliation
  • Cometta A; Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Antimicrob Agents Chemother ; 40(5): 1108-15, 1996 May.
Article in En | MEDLINE | ID: mdl-8723449

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thienamycins / Agranulocytosis / Drug Therapy, Combination / Fever Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Infant / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 1996 Document type: Article Affiliation country: Suiza Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thienamycins / Agranulocytosis / Drug Therapy, Combination / Fever Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Infant / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 1996 Document type: Article Affiliation country: Suiza Country of publication: Estados Unidos